Table 2 Patient baseline characteristics by model response type
Response type | All patients, n | Sensitive baseline mutation,*n (%) | Insensitive baseline mutation,†n (%) | Imatinib-resistant, n (%) | Imatinib-intolerant, n (%) |
|---|---|---|---|---|---|
Slow (monophasic) | 65 | 21 (32.3) | 18 (27.7) | 58 (89.2) | 7 (10.8) |
Fast (biphasic) | 58 | 18 (31.0) | 2 (3.4) | 42 (72.4) | 16 (27.6) |